Crossmark

Lactoferrin-modified PLGA nanoparticles for pregabalin: development, characterization, in vitro targeting and pharmacodynamic evaluation

Published Online: 2025-04-08

Published Print: 2025-12

Authors

Rai, Garima

Gauba, Pammi

Tyagi, Amit

Dang, Shweta https://orcid.org/0000-0002-2924-8996
Funding

Funding for this research was provided by:

Indian Council of Medical Research (F.No.33/3/2019TF/Rare/BMS)
License Information

Text and Data Mining valid from 2025-04-08

Version of Record valid from 2025-04-08
More Information

Article History

Accepted: 24 March 2025

First Online: 8 April 2025

Declarations

:

: The study was conducted by adhering to the National Guidelines for the Care and Use of Laboratory Animals in INMAS, DRDO, New Delhi. We obtained authorization from the Animal Ethical Committee, IAEC, New Delhi, India (INM/IAEC/2018/15Ext02).

: The authors declare that there is no conflict of interest.

Document is current